EP3346912A4 - Procédé et système pour des diagnostics dérivés du microbiome et agents thérapeutiques pour des affections associées à la santé cérébro-carniofaciale - Google Patents

Procédé et système pour des diagnostics dérivés du microbiome et agents thérapeutiques pour des affections associées à la santé cérébro-carniofaciale Download PDF

Info

Publication number
EP3346912A4
EP3346912A4 EP16845218.3A EP16845218A EP3346912A4 EP 3346912 A4 EP3346912 A4 EP 3346912A4 EP 16845218 A EP16845218 A EP 16845218A EP 3346912 A4 EP3346912 A4 EP 3346912A4
Authority
EP
European Patent Office
Prior art keywords
cerebro
microbiome
therapeutics
conditions associated
derived diagnostics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP16845218.3A
Other languages
German (de)
English (en)
Other versions
EP3346912A1 (fr
Inventor
Zachary APTE
Jessica RICHMAN
Daniel Almonacid
Siavosh Rezvan BEHBAHANI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Psomagen Inc
Original Assignee
uBiome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by uBiome Inc filed Critical uBiome Inc
Publication of EP3346912A1 publication Critical patent/EP3346912A1/fr
Publication of EP3346912A4 publication Critical patent/EP3346912A4/fr
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G16B30/10—Sequence alignment; Homology search
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/70—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mental therapies, e.g. psychological therapy or autogenous training
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Public Health (AREA)
  • Data Mining & Analysis (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Databases & Information Systems (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Primary Health Care (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Software Systems (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • Artificial Intelligence (AREA)
  • Bioethics (AREA)
  • Wood Science & Technology (AREA)
  • Evolutionary Computation (AREA)
  • Hospice & Palliative Care (AREA)
  • Child & Adolescent Psychology (AREA)
  • Social Psychology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
EP16845218.3A 2015-09-09 2016-09-09 Procédé et système pour des diagnostics dérivés du microbiome et agents thérapeutiques pour des affections associées à la santé cérébro-carniofaciale Pending EP3346912A4 (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201562216028P 2015-09-09 2015-09-09
US201562216016P 2015-09-09 2015-09-09
US201562215939P 2015-09-09 2015-09-09
US201562216042P 2015-09-09 2015-09-09
US201562216035P 2015-09-09 2015-09-09
PCT/US2016/051155 WO2017044885A1 (fr) 2015-09-09 2016-09-09 Procédé et système pour des diagnostics dérivés du microbiome et agents thérapeutiques pour des affections associées à la santé cérébro-carniofaciale

Publications (2)

Publication Number Publication Date
EP3346912A1 EP3346912A1 (fr) 2018-07-18
EP3346912A4 true EP3346912A4 (fr) 2019-08-21

Family

ID=58240338

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16845218.3A Pending EP3346912A4 (fr) 2015-09-09 2016-09-09 Procédé et système pour des diagnostics dérivés du microbiome et agents thérapeutiques pour des affections associées à la santé cérébro-carniofaciale

Country Status (5)

Country Link
EP (1) EP3346912A4 (fr)
CN (1) CN108348167B (fr)
AU (1) AU2016321333A1 (fr)
CA (1) CA3006044A1 (fr)
WO (1) WO2017044885A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10395777B2 (en) 2014-10-21 2019-08-27 uBiome, Inc. Method and system for characterizing microorganism-associated sleep-related conditions
US10777320B2 (en) 2014-10-21 2020-09-15 Psomagen, Inc. Method and system for microbiome-derived diagnostics and therapeutics for mental health associated conditions
AU2015335907A1 (en) 2014-10-21 2017-04-13 Psomagen, Inc. Method and system for microbiome-derived diagnostics and therapeutics
US10366793B2 (en) 2014-10-21 2019-07-30 uBiome, Inc. Method and system for characterizing microorganism-related conditions
WO2018094376A1 (fr) * 2016-11-21 2018-05-24 uBiome, Inc. Procédé et système pour caractériser une affection liée à une céphalée
WO2018223146A1 (fr) * 2017-06-02 2018-12-06 uBiome, Inc. Procédé et système destinés à la caractérisation de troubles liés au sommeil apparentés à un microorganisme
US11154240B2 (en) 2019-04-02 2021-10-26 Kpn Innovations Llc Methods and systems for utilizing diagnostics for informed vibrant constitutional guidance
US11289206B2 (en) 2020-06-02 2022-03-29 Kpn Innovations, Llc. Artificial intelligence methods and systems for constitutional analysis using objective functions
US12176108B2 (en) 2020-06-02 2024-12-24 Kpn Innovations Llc Artificial intelligence methods and systems for constitutional analysis using objective functions
US11211158B1 (en) 2020-08-31 2021-12-28 Kpn Innovations, Llc. System and method for representing an arranged list of provider aliment possibilities
CN113096818B (zh) * 2021-04-21 2023-05-30 西安电子科技大学 基于ode和grud的急性病症发生几率的评估方法

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013176774A1 (fr) * 2012-05-25 2013-11-28 Arizona Board Of Regents Marqueurs de microbiome et thérapies pour troubles du spectre autistique
US20140301995A1 (en) * 2011-10-12 2014-10-09 Gut Guide Oy Raising and Diagnosing of Serotonin Level
WO2014179965A1 (fr) * 2013-05-09 2014-11-13 The Procter & Gamble Company Procédé et système d'identification d'un marqueur biologique
US20150211078A1 (en) * 2014-01-25 2015-07-30 uBiome, Inc. Method and system for microbiome analysis
WO2016065075A1 (fr) * 2014-10-21 2016-04-28 uBiome, Inc. Procédé et système de diagnostic et de thérapie fondés sur le microbiome
US20160232280A1 (en) * 2014-10-21 2016-08-11 uBiome, Inc. Method and system for microbiome-derived characterization, diagnostics and therapeutics for cardiovascular disease conditions

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060228721A1 (en) * 2005-04-12 2006-10-12 Leamon John H Methods for determining sequence variants using ultra-deep sequencing
EP2201134B1 (fr) * 2007-09-19 2018-11-21 The Research Foundation of State University of New York Signatures de l'expression génique dans des échantillons de cellules tumorales enrichis
CN104195227B (zh) * 2008-11-07 2017-04-12 适应生物技术公司 通过序列分析监测状况的方法
WO2011022660A1 (fr) * 2009-08-21 2011-02-24 Puretech Ventures, Llc Procédés de diagnostic et de traitement de maladie associée au microbiome au moyen de paramètres de réseau d’interaction
EP3657507A1 (fr) * 2010-05-25 2020-05-27 The Regents of The University of California Bambam analyse comparative parallèle de données de séquençage à rendement élevé
KR20130113476A (ko) * 2010-10-27 2013-10-15 ?티백트 에이/에스 인터칼레이터 （ｉｎｔｅｒｃａｌａｔｏｒ） 분자를 포함하는 프로브에 의한 표적 ＤＮＡ 및 ＲＮＡ의 캡쳐
WO2012103337A2 (fr) * 2011-01-26 2012-08-02 The Brigham And Women's Hospital, Inc. Dosages et procédé de séquençage de microbes directement à partir de complexes immuns
KR20190107761A (ko) * 2011-03-09 2019-09-20 셀 시그널링 테크놀러지, 인크. 모노클로날 항체를 생성하는 방법 및 시약
US20130121968A1 (en) * 2011-10-03 2013-05-16 Atossa Genetics, Inc. Methods of combining metagenome and the metatranscriptome in multiplex profiles
CN104364394B (zh) * 2012-03-17 2019-02-22 加州大学评议会 痤疮的快速诊断和个体化治疗
CN103374518B (zh) * 2012-04-12 2018-03-27 维里纳塔健康公司 拷贝数变异的检测和分类
EP4026912A1 (fr) * 2012-05-10 2022-07-13 The General Hospital Corporation Procédés de détermination d'une séquence nucléotidique
EP3241902B1 (fr) * 2012-05-25 2018-02-28 The Regents of The University of California Procédés et compositions permettant la modification de l'adn cible dirigée par l'arn et la modulation de la transcription dirigée par l'arn
US20150125438A1 (en) * 2012-07-20 2015-05-07 Sang Jae Kim Anti-Inflammatory Peptides and Composition Comprising the Same
CN104540962B (zh) * 2012-08-01 2017-09-19 深圳华大基因研究院 糖尿病生物标志物及其应用
CA2899925A1 (fr) * 2013-02-04 2014-08-07 Seres Therapeutics, Inc. Compositions et procedes pour l'inhibition de croissance bacterienne pathogene
US10253377B2 (en) * 2013-04-05 2019-04-09 Wayne State University Systems and methods to assess microbiomes and treatments thereof
WO2015074054A1 (fr) * 2013-11-18 2015-05-21 The Trustees Of Columbia University In The City Of New York Amélioration de la santé microbienne dans l'intestin de mammifères
CN104195145B (zh) * 2014-07-15 2017-01-18 浙江大学 肝硬化的生物标志物及其应用
US10265009B2 (en) * 2014-10-21 2019-04-23 uBiome, Inc. Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome taxonomic features

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140301995A1 (en) * 2011-10-12 2014-10-09 Gut Guide Oy Raising and Diagnosing of Serotonin Level
WO2013176774A1 (fr) * 2012-05-25 2013-11-28 Arizona Board Of Regents Marqueurs de microbiome et thérapies pour troubles du spectre autistique
WO2014179965A1 (fr) * 2013-05-09 2014-11-13 The Procter & Gamble Company Procédé et système d'identification d'un marqueur biologique
US20150211078A1 (en) * 2014-01-25 2015-07-30 uBiome, Inc. Method and system for microbiome analysis
WO2016065075A1 (fr) * 2014-10-21 2016-04-28 uBiome, Inc. Procédé et système de diagnostic et de thérapie fondés sur le microbiome
US20160232280A1 (en) * 2014-10-21 2016-08-11 uBiome, Inc. Method and system for microbiome-derived characterization, diagnostics and therapeutics for cardiovascular disease conditions

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2017044885A1 *

Also Published As

Publication number Publication date
CN108348167B (zh) 2022-06-03
AU2016321333A1 (en) 2018-04-26
CA3006044A1 (fr) 2017-03-16
EP3346912A1 (fr) 2018-07-18
WO2017044885A1 (fr) 2017-03-16
CN108348167A (zh) 2018-07-31

Similar Documents

Publication Publication Date Title
EP3347495A4 (fr) Procédé et système pour des diagnostics dérivés du microbiome et agents thérapeutiques pour des affections associées à la santé gastro-intestinale
EP3209803A4 (fr) Procédé et système de diagnostic et de thérapie fondés sur le microbiome
EP3347496A4 (fr) Méthode et système de diagnostics dérivés du microbiome et traitements thérapeutiques pour la santé bucco-dentaire
EP3317428A4 (fr) Procédé et système destinés à un essai diagnostique
EP3346912A4 (fr) Procédé et système pour des diagnostics dérivés du microbiome et agents thérapeutiques pour des affections associées à la santé cérébro-carniofaciale
EP3187112A4 (fr) Système d'imagerie ct statique en temps réel et procédé de commande d'imagerie
EP3090416A4 (fr) Procede et systeme de surveillance
EP3283086A4 (fr) Procédé et système de diagnostic et de traitement dérivés du microbiome pour des pathologies associées aux caractéristiques fonctionnelles du microbiome
EP3299918A4 (fr) Système de diagnostic d'anomalies et procédé de diagnostic d'anomalies
EP3229093A4 (fr) Procédé de diagnostic d'anomalie et système de diagnostic d'anomalie
EP3327402A4 (fr) Système et procédé d'inspection
EP3273648A4 (fr) Système et procédé
EP3270096A4 (fr) Système de mesure, procédé de mesure et programme de mesure
EP3105965A4 (fr) Système et procédé de ré-hébergement de connexion
EP3111700A4 (fr) Système et procédé de transfert spécifique à un ue
EP3283084A4 (fr) Procédé et système de caractérisation, de diagnostics et de traitements dérivés du microbiome pour des dermatoses
EP3270097A4 (fr) Système de mesure, procédé de mesure et programme de mesure
EP3283649A4 (fr) Procédé et système pour la caractérisation, le diagnostic et le traitement dérivés du microbiome de pathologies cardiovasculaires
EP3283652A4 (fr) Procédé et système pour des diagnostics et des traitements thérapeutiques, dérivés du microbiome, de pathologies associées à la santé mentale
GB201510480D0 (en) System and method
IL230969A0 (en) A network-based system and method for influence
EP3347494A4 (fr) Méthode et système de diagnostics et de thérapies dérivés du microbiome destinés à des affections associées à des problèmes de santé de la thyroïde
EP3120162A4 (fr) Système et procédé pour effectuer un diagnostic de transformateur
GB201510000D0 (en) System and method
EP3335380A4 (fr) Procédé et système de diagnostic de transaction

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20180406

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: G16B 20/00 20190101ALI20190410BHEP

Ipc: G16B 40/20 20190101ALI20190410BHEP

Ipc: C12Q 1/68 20180101ALI20190410BHEP

Ipc: G16H 50/20 20180101AFI20190410BHEP

Ipc: G16H 50/70 20180101ALI20190410BHEP

Ipc: A61B 5/00 20060101ALI20190410BHEP

REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: A61B0005000000

Ipc: G16H0050200000

A4 Supplementary search report drawn up and despatched

Effective date: 20190718

RIC1 Information provided on ipc code assigned before grant

Ipc: A61B 5/00 20060101ALI20190712BHEP

Ipc: C12Q 1/68 20180101ALI20190712BHEP

Ipc: G16H 50/70 20180101ALI20190712BHEP

Ipc: G16B 20/00 20190101ALI20190712BHEP

Ipc: G16B 40/20 20190101ALI20190712BHEP

Ipc: G16H 50/20 20180101AFI20190712BHEP

19U Interruption of proceedings before grant

Effective date: 20191011

19W Proceedings resumed before grant after interruption of proceedings

Effective date: 20201201

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: PSOMAGEN, INC.

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20231122